Nanophase Technologies Corp
OTC:NANX
Nanophase Technologies Corp
OTC:NANX
Price:
5.21
USD
13.26%
Market Closed
Market Cap:
$364.6m
Balance Sheet
Balance Sheet Decomposition
Nanophase Technologies Corp
Nanophase Technologies Corp
Balance Sheet Decomposition is not available for
Nanophase Technologies Corp
Nanophase Technologies Corp
Balance Sheet
Nanophase Technologies Corp
Nanophase Technologies Corp
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Cash Equivalents |
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
1
|
1
|
1
|
3
|
4
|
5
|
3
|
|
| Accounts Receivables |
0
|
1
|
0
|
1
|
1
|
1
|
3
|
4
|
5
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
1
|
2
|
3
|
4
|
6
|
9
|
10
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
4
|
3
|
3
|
5
|
5
|
5
|
9
|
12
|
17
|
16
|
|
| PP&E Net |
2
|
2
|
1
|
2
|
2
|
4
|
5
|
17
|
17
|
17
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
4
|
5
|
17
|
17
|
17
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
20
|
20
|
21
|
21
|
22
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
5
-20%
|
5
+6%
|
6
+30%
|
7
+5%
|
9
+43%
|
14
+45%
|
28
+110%
|
34
+18%
|
33
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
4
|
6
|
6
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
3
|
1
|
7
|
3
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Total Current Liabilities |
1
|
1
|
1
|
2
|
4
|
4
|
7
|
7
|
17
|
16
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
6
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
13
|
10
|
9
|
|
| Total Liabilities |
2
N/A
|
2
-9%
|
2
+20%
|
3
+48%
|
5
+71%
|
8
+51%
|
11
+38%
|
21
+94%
|
28
+33%
|
31
+11%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
92
|
94
|
95
|
96
|
98
|
101
|
100
|
97
|
100
|
105
|
|
| Additional Paid In Capital |
96
|
96
|
97
|
99
|
99
|
102
|
102
|
104
|
105
|
106
|
|
| Total Equity |
4
N/A
|
3
-26%
|
3
-2%
|
3
+16%
|
1
-57%
|
2
+9%
|
3
+81%
|
7
+174%
|
6
-24%
|
2
-66%
|
|
| Total Liabilities & Equity |
6
N/A
|
5
-20%
|
5
+6%
|
6
+30%
|
7
+5%
|
9
+43%
|
14
+45%
|
28
+110%
|
34
+18%
|
33
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
29
|
29
|
31
|
34
|
34
|
38
|
38
|
49
|
49
|
50
|
|
Switch to:
Switch to:
See Also
Discover More
